RAC (ASX) share price forecast & AI signal — Racura Oncology Ltd
Week of 2026-10-30 · Pharmaceuticals, Biotechnology & Life Sciences
Exact confidence, 1-week / 1-month / 3-month breakdown, plain-English AI write-up, bull-vs-bear debate, support & resistance.
Get 5 free tokens — no card Already a member? Open the full analysisWhat the model sees in RAC
Racura Oncology Ltd is a Pharmaceuticals, Biotechnology & Life Sciences stock listed on the ASX. For the week of 2026-10-30 the ACE machine-learning model rates it a SELL with moderate confidence, based on technical indicators and the stock's own historical patterns across three time horizons. The direction is updated every model run.
About Racura Oncology Ltd
Race Oncology Ltd is a biotechnology company focused on developing cancer treatments. The company's lead drug candidate is Bisantrene, which is being investigated for the treatment of acute myeloid leukemia (AML). Race Oncology is headquartered in Australia and is listed on the Australian Securities Exchange (ASX) under the ticker symbol RAC.
Recent closes
| Date | Close |
|---|---|
| 2026-11-06 | $1.48 |
| 2026-11-05 | $1.48 |
| 2026-11-04 | $1.40 |
| 2026-11-03 | $1.45 |
| 2026-11-02 | $1.47 |
| 2026-10-30 | $1.54 |
| 2026-10-29 | $1.55 |
RAC FAQ
Is Racura Oncology Ltd (RAC) a buy or sell this week?
The ACE Stock Bots machine-learning model rates RAC a SELL for the week of 2026-10-30 with moderate confidence. The exact confidence and the 1-week, 1-month and 3-month breakdown are free with a signup (5 analysis tokens, no card).
What is the AI share price forecast for RAC?
Every week the model scores RAC across three horizons using technical indicators and the stock's own historical patterns. An AI then writes a plain-English summary with support and resistance levels, and a bull analyst and a bear analyst argue the case.
Is this financial advice?
No. ACE Stock Bots provides general information generated by software. It does not consider your objectives, financial situation or needs. Read the disclaimer and consider licensed advice before acting.
Other Pharmaceuticals, Biotechnology & Life Sciences stocks on the ASX
This week's top ASX picks · All ASX stocks
Signals are generated by software for general information only and are not a recommendation to buy or sell. See the disclaimer.